Please Wait.....
Report
Argentina In Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 90 Pages I Mordor Intelligence
Argentina In Vitro Diagnostics Market Analysis
Argentina in vitro diagnostics market was valued at USD 0.84 billion in 2025 and is forecast to reach USD 1.09 billion by 2030, expanding at a 5.4% CAGR. Rising chronic disease prevalence, wider private insurance uptake and public-sector lab upgrades are the primary engines of growth. Currency volatility, however, continues to raise the landed cost of imported analyzers and consumables, prompting hospitals to explore locally made reagents. Precision-medicine programs are stimulating demand for molecular assays, while mandatory e-prescriptions effective January 2025 link test data directly to clinical workflows. Opportunities also stem from point-of-care platforms that extend diagnostics into remote provinces.
Argentina In Vitro Diagnostics Market Trends and Insights
Burden of Chronic & Infectious Diseases Boosting Diagnostic Demand
Non-communicable diseases account for 78% of Argentina's disease burden, and cardiovascular ailments alone cause 30% of annual deaths. High mortality from chronic kidney disease, with an age-standardized rate of 9.2 per 100,000, underscores the need for earlier testing. Hospitals are therefore investing in biomarker and molecular panels that shorten therapeutic decision times. Expanded HIV and STI screening programs further lift reagent volumes. Together these factors underpin steady unit growth across the Argentina in vitro diagnostics market.
Government Modernization of Public Laboratories & Test Reimbursement
The National Digital Health Strategy promotes interoperable lab information systems, while Programa Sumar ties provincial funding to performance indicators. SENASA's expanded laboratory network improves nationwide sample logistics. These actions stimulate procurement of analyzers compatible with electronic prescription workflows, accelerating data-driven diagnostics in the Argentina in vitro diagnostics market.
Currency Volatility Elevating Import Costs for Instruments & Consumables
Multiple exchange rates and capital controls lift the peso cost of imported analyzers, forcing providers to delay upgrades. Even as the federal budget posted a primary surplus in 2024, recurrent devaluation inflated reagent invoices by double digits. Vendors often denominate quotes in USD, adding hedging surcharges that compress hospital margins and slow high-end segment adoption inside the Argentina in vitro diagnostics market.
Other drivers and restraints analyzed in the detailed report include:
Expansion of Private Health Insurance / Shift Toward Point-of-Care Testing in Underserved Provinces / Fragmented Provincial Procurement Hindering Volume-based Pricing /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Clinical Chemistry generated 28% of Argentina in vitro diagnostics market share in 2024 on the back of high-volume lipid, renal and liver panels used for chronic disease monitoring. Routine deployment across public and private labs ensures predictable reagent pull-through. Yet reimbursement ceilings cap price escalation, prompting vendors to focus on reagent stability to protect margins. Immunodiagnostics maintains traction in HIV and hepatitis screening, where algorithmic confirmatory testing drives repeat orders.
Molecular Diagnostics is forecast to post a 9.2% CAGR, the swiftest within the Argentina in vitro diagnostics market. COVID era capacity remains in place, repurposed toward oncogenic mutation detection and multi-pathogen respiratory panels. Laboratories in Buenos Aires and Cordoba are validating liquid biopsy workflows despite staffing gaps that slow nationwide rollout. The segment's rise signals a long-term tilt toward precision medicine, though test affordability remains a hurdle away from major metros.
Reagents & Consumables delivered 67% of Argentina in vitro diagnostics market size in 2024 due to the consumable nature of chemistry, immunoassay and PCR workflows. Currency swings have made single-source contracts desirable, pushing health systems to cultivate local suppliers. The emergent domestic reagent consortium, backed by academic know-how, is shortening lead times and stabilizing kit pricing for provincial hospitals.
Software & Services is projected to grow 10.9% per year as e-prescription mandates drive adoption of lab information systems. Middleware that consolidates analyzer outputs into clinical records elevates data integrity and meets audit requirements. Vendors offering turnkey integration with hospital EMR suites enjoy an early-mover edge in the Argentina in vitro diagnostics market, particularly where cloud connectivity is feasible.
The Argentina in Vitro Diagnostics Market is Segmented by Test Type (Clinical Chemistry, Immunodiagnostics, and More), Product (Instruments / Analyzers, and More), Technology (ELISA / CLIA, and More) Usability (Disposable and Reusable), Application (Infectious Diseases, Diabetes, Cardiology and More), and End Users (Diagnostic Laboratories, Hospitals & Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories / Roche / Siemens Healthineers / bioMerieux / Danaher Corp. (Beckman Coulter & Cepheid) / Thermo Fisher Scientific / QIAGEN / Sysmex / DiaSorin / Illumina / Laboratorio Elea Phoenix S.A. / Bio-Rad Laboratories / Hologic / Grifols / Werfen (Instrumentation Laboratory) / Ortho Clinical Diagnostics Holdings plc / Randox Laboratories / Eurofins / Merck KGaA (MilliporeSigma) / Wiener Laboratorios S.A.I.C. / Genomica (PharmaMar Group) /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Burden of Chronic & Infectious Diseases Boosting Diagnostic Demand
4.2.2 Government Modernization of Public Laboratories & Test Reimbursement
4.2.3 Expansion of Private Health Insurance
4.2.4 Local Reagent Manufacturing Initiatives Enhancing Supply Security
4.2.5 Shift Toward Point-of-Care Testing in Underserved Provinces
4.2.6 Post-COVID Acceleration of Molecular & Immunoassay Platform Adoption
4.3 Market Restraints
4.3.1 Currency Volatility Elevating Import Costs for Instruments & Consumables
4.3.2 Fragmented Provincial Procurement Hindering Volume-based Pricing
4.3.3 Shortage of Skilled Laboratory Workforce Outside Major Urban Centers
4.3.4 Extended ANMAT Approval Cycles Delaying Market Entry
4.4 Regulatory Outlook
4.5 Technological Outlook
4.6 Porter's Five Forces
4.6.1 Bargaining Power of Buyers
4.6.2 Bargaining Power of Suppliers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Immunodiagnostics
5.1.3 Molecular Diagnostics
5.1.4 Hematology
5.1.5 Coagulation & Hemostasis
5.1.6 Microbiology
5.1.7 Point-of-Care Lateral Flow
5.1.8 Other Test Types
5.2 By Product
5.2.1 Instruments / Analyzers
5.2.2 Reagents & Consumables
5.2.3 Software & Services
5.3 By Technology
5.3.1 ELISA / CLIA
5.3.2 Real-time PCR & Isothermal NAAT
5.3.3 NGS Panels
5.3.4 Microarrays & Lab-on-Chip
5.3.5 Lateral-Flow Immunoassay
5.3.6 Flow Cytometry
5.4 By Usability
5.4.1 Disposable (Single-use Cartridges)
5.4.2 Reusable (Bench-top Analyzers)
5.5 By Application
5.5.1 Infectious Diseases
5.5.2 Diabetes
5.5.3 Cancer / Oncology Biomarkers
5.5.4 Cardiology
5.5.5 Autoimmune & Inflammatory Disorders
5.5.6 Nephrology
5.5.7 Blood Screening & Transfusion Safety
5.5.8 Other Applications
5.6 By End User
5.6.1 Diagnostic Reference Laboratories
5.6.2 Hospitals & Clinics
5.6.3 Point-of-Care Settings (Polyclinics, Ambulances)
5.6.4 Home & Self-Testing Channels
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 F. Hoffmann-La Roche Ltd.
6.3.3 Siemens Healthineers AG
6.3.4 bioMerieux SA
6.3.5 Danaher Corp. (Beckman Coulter & Cepheid)
6.3.6 Thermo Fisher Scientific Inc.
6.3.7 QIAGEN N.V.
6.3.8 Sysmex Corporation
6.3.9 DiaSorin S.p.A.
6.3.10 Illumina Inc.
6.3.11 Laboratorio Elea Phoenix S.A.
6.3.12 Bio-Rad Laboratories Inc.
6.3.13 Hologic Inc.
6.3.14 Grifols S.A.
6.3.15 Werfen (Instrumentation Laboratory)
6.3.16 Ortho Clinical Diagnostics Holdings plc
6.3.17 Randox Laboratories Ltd.
6.3.18 Eurofins Scientific SE
6.3.19 Merck KGaA (MilliporeSigma)
6.3.20 Wiener Laboratorios S.A.I.C.
6.3.21 Genomica (PharmaMar Group)
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security